vertex News
Most Popular vertex Story
UPDATED: Vertex nabs expedited FDA OK on breakthrough CF drug
Vertex Pharmaceuticals ($VRTX) is no longer a one-trick biotech company. The FDA issued an early approval today for Kalydeco (ivacaftor), a new drug that promises to strengthen the lungs and ease Read more...
Latest Headlines
- February 9, 2012
- February 7, 2012
- January 31, 2012
- January 24, 2012
- January 5, 2012
- December 15, 2011
- December 14, 2011
- November 30, 2011
- November 9, 2011
- November 8, 2011
- October 28, 2011
- October 19, 2011
- September 30, 2011
- September 16, 2011
- September 14, 2011
- August 19, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
